Richard Law – Credit Suisse

Credit Suisse

A Credit Suisse analyst with 16 tracked ratings across 12 distinct tickers has a 35.7% success rate on the captured sample, primarily issuing hold ratings.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

2 years ago

2023-08-11 00:00:00+00

Track record

Aggregated

36% success rate

Bullish: 4
Hold: 12
Bearish: 0

Aggregated

Not available

Bullish: 3
Hold: 4
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
GLUE	2023-08-11	hold	$11.00	Aggregated
BEAM	2023-08-09	hold	$47.00	Aggregated
BEAMBEAM THERAPEUTICS INC	2023-08-09	hold	$47.00	Aggregated
OLMA	2023-08-09	buy	$18.00	Aggregated
OLMAOLEMA PHARMACEUTICALS INC	2023-08-09	unknown	$18.00	Aggregated
CRSP	2023-08-08	hold	$63.00	Aggregated
CRSPCRISPR THERAPEUTICS AG	2023-08-08	hold	$63.00	Aggregated
MLYS	2023-08-08	buy	$37.00	Aggregated
MLYSMINERALYS THERAPEUTICS INC	2023-08-08	unknown	$37.00	Aggregated
NTLA	2023-06-13	buy	$76.00	Aggregated
NTLAINTELLIA THERAPEUTICS INC	2023-06-13	unknown	$76.00	Aggregated
KYMR	2023-06-05	hold	$36.00	Aggregated
KYMRKYMERA THERAPEUTICS INC	2023-06-05	hold	$36.00	Aggregated
MLYS	2023-05-16	buy	$38.00	Aggregated
GLUE	2023-05-12	hold	$11.00	Aggregated
ARVN	2023-05-08	buy	$61.00	Aggregated
ARVNARVINAS INC	2023-05-08	unknown	$61.00	Aggregated
EDIT	2023-05-08	hold	$14.00	Aggregated
EDITEDITAS MEDICINE INC	2023-05-08	hold	$14.00	Aggregated
GLUE	2023-03-17	hold	$11.00	Aggregated
MLYS	2023-03-16	buy	$38.00	Aggregated
EDIT	2022-12-06	hold	$13.00	Aggregated
VERV	2022-10-06	hold	$48.00	Aggregated
VERVVERVE THERAPEUTICS INC	2022-10-06	hold	$48.00	Aggregated
GLUE	2022-04-28	hold	$19.00	Aggregated
GLUEMONTE ROSA THERAPEUTICS INC	2022-04-28	hold	$19.00	Aggregated

Tickers covered(20)

Ticker	Ratings	Last rating	Sources
GLUE	4	2023-08-11	Aggregated
BEAM	1	2023-08-09	Aggregated
BEAMBEAM THERAPEUTICS INC	1	2023-08-09	Aggregated
OLMA	2	2023-08-09	Aggregated
OLMAOLEMA PHARMACEUTICALS INC	1	2023-08-09	Aggregated
CRSP	1	2023-08-08	Aggregated
CRSPCRISPR THERAPEUTICS AG	1	2023-08-08	Aggregated
MLYS	5	2023-08-08	Aggregated
MLYSMINERALYS THERAPEUTICS INC	1	2023-08-08	Aggregated
NTLA	2	2023-06-13	Aggregated
NTLAINTELLIA THERAPEUTICS INC	1	2023-06-13	Aggregated
KYMR	1	2023-06-05	Aggregated
KYMRKYMERA THERAPEUTICS INC	1	2023-06-05	Aggregated
ARVN	2	2023-05-08	Aggregated
ARVNARVINAS INC	1	2023-05-08	Aggregated
EDIT	2	2023-05-08	Aggregated
EDITEDITAS MEDICINE INC	1	2023-05-08	Aggregated
VERV	1	2022-10-06	Aggregated
VERVVERVE THERAPEUTICS INC	1	2022-10-06	Aggregated
GLUEMONTE ROSA THERAPEUTICS INC	1	2022-04-28	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.